Diagnostic value of carcinoembryonic antigen in exudative pleural effusions. 1980

J M McKenna, and A J Chandrasekhar, and R E Henkin

Elevated pleural fluid (PF) and plasma (PL) carcinoembryonic antigen (CEA) levels (ng/ml) were more frequently found with malignant than benign exudative effusions, but with a low true-positive rate for malignancy in general. Adenocarcinomatous effusions differed from other malignant and benign effusions in the frequency and degree of elevation of PF and PL CEA levels. A PF > 20 had a sensitivity of 91 percent and a specificity of 92 percent as a screening test for adenocarcinomatous effusions. A PF CEA > 55 or PL CEA > 10 were present only with malignancy and 98 percent specific for adenocarcinoma.

UI MeSH Term Description Entries
D010996 Pleural Effusion Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself. Effusion, Pleural,Effusions, Pleural,Pleural Effusions
D010997 Pleural Neoplasms Neoplasms of the thin serous membrane that envelopes the lungs and lines the thoracic cavity. Pleural neoplasms are exceedingly rare and are usually not diagnosed until they are advanced because in the early stages they produce no symptoms. Neoplasms, Pleural,Neoplasm, Pleural,Pleural Neoplasm
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas

Related Publications

J M McKenna, and A J Chandrasekhar, and R E Henkin
October 1984, Tumori,
J M McKenna, and A J Chandrasekhar, and R E Henkin
March 1984, Cancer,
J M McKenna, and A J Chandrasekhar, and R E Henkin
February 1989, The Indian journal of medical research,
J M McKenna, and A J Chandrasekhar, and R E Henkin
January 2012, Asian Pacific journal of cancer prevention : APJCP,
J M McKenna, and A J Chandrasekhar, and R E Henkin
August 1978, Lancet (London, England),
J M McKenna, and A J Chandrasekhar, and R E Henkin
November 1978, Lancet (London, England),
J M McKenna, and A J Chandrasekhar, and R E Henkin
November 2011, Experimental and therapeutic medicine,
J M McKenna, and A J Chandrasekhar, and R E Henkin
June 2002, European journal of internal medicine,
J M McKenna, and A J Chandrasekhar, and R E Henkin
January 1988, Vojnosanitetski pregled,
J M McKenna, and A J Chandrasekhar, and R E Henkin
February 1979, American journal of clinical pathology,
Copied contents to your clipboard!